Table 3 Univariate and multivariate analysis of disease-free survival
Univariant analysis | p-value | Multivariant analysis | p-value | |
|---|---|---|---|---|
HR (95% CI) | HR (95% CI) | |||
Gender:male/female | 0.77 (0.37–1.59) | NS | ||
Child-Pugh score: A/B | 0.94 (0.32–1.61) | NS | ||
HBV DNA ≤ 4 (log copies/mL) | 0.71 (0.33–1.54) | NS | ||
HBeAg: negative/positive | 0.61 (0.11–0.91) | < 0.05 | ||
Non-cirrhosis/Cirrhosis | 0.47 (0.21–0.98) | < 0.05 | 0.41 (0.13–0.77) | < 0.05 |
Total bilirubin: < 24/≥ 24 (μmol/L) | 1.15 (0.69–1.91) | NS | ||
TDF treatment/ETV treatment | 0.78 (0.43–0.97) | < 0.05 | 0.35 (0.33–0.84) | < 0.05 |